Inhibrx Biosciences, Inc. INBX Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $101.37M-42.7% | $113.03M-44.5% | $121.05M-52.1% | $131.4M-47.8% | $176.77M-19.0% | ||
| $22.98M-81.5% | $23.3M-81.8% | $34.38M-71.1% | $37.01M-68.9% | $123.96M+276% | ||
| $124.35M-58.6% | $136.33M-58.9% | $155.43M-58.2% | $168.42M-54.6% | $300.72M+19.8% | ||
| -$123.05M+59.1% | -$135.03M+59.3% | -$154.03M+58.3% | -$167.02M+54.7% | -$300.52M-20.6% | ||
| $13.02M+61.7% | $12.2M-9.6% | $9.01M-58.5% | $5.83M-80.5% | $8.05M-75.2% | ||
| -$7.13M-100% | -$5.03M-100% | -$1.05M-100% | $3.32M-99.8% | $2.02B+10,099% | ||
| -$130.18M-107% | -$140.05M-108% | -$107.22M-107% | -$115.83M-107% | $1.77B+757% | ||
| $2K0.0% | $2K0.0% | $2K— | $2K— | $2K— | ||
| -$130.19M-107% | -$140.06M-108% | -$107.22M-107% | -$115.83M-107% | $1.77B+753% | ||
| -$8.39-107% | -$9.04-108% | -$6.93-106% | -$7.49-107% | $119.84+651% | ||
| -$120.71M+59.5% | -$132.54M+59.7% | -$151.42M+58.8% | -$164.23M+55.3% | -$297.93M-20.1% | ||
| -$123.05M+59.1% | -$135.03M+59.3% | -$154.03M+58.3% | -$167.02M+54.7% | -$300.52M-20.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Inhibrx Biosciences, Inc.'s revenue?
- Inhibrx Biosciences, Inc. (INBX) generated $1.3M in revenue over the trailing twelve months, up 550.0% year over year.
- Is Inhibrx Biosciences, Inc. profitable?
- Inhibrx Biosciences, Inc. is not currently profitable: it reported a net loss of $130.2M over the trailing twelve months, a -10773.5% net margin.
- What is Inhibrx Biosciences, Inc.'s earnings per share?
- Inhibrx Biosciences, Inc.'s diluted EPS over the trailing twelve months is $-8.39.
- Where does Inhibrx Biosciences, Inc.'s income statement data come from?
- Every line is extracted from Inhibrx Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
